Identifying Predictive Gene Expression and Signature Related to Temozolomide Sensitivity of Glioblastomas

Temozolomide (TMZ) is considered a standard chemotherapeutic agent for glioblastoma (GBM). Characterizing the biological molecules and signaling pathways involved in TMZ sensitivity would be helpful for selecting therapeutic schemes and evaluating prognosis for GBM. Thus, in the present study, we se...

Descripción completa

Detalles Bibliográficos
Autores principales: Cai, Hong-Qing, Liu, Ang-Si, Zhang, Min-Jie, Liu, Hou-Jie, Meng, Xiao-Li, Qian, Hai-Peng, Wan, Jing-Hai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7258082/
https://www.ncbi.nlm.nih.gov/pubmed/32528873
http://dx.doi.org/10.3389/fonc.2020.00669

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7258082/
https://www.ncbi.nlm.nih.gov/pubmed/32528873
http://dx.doi.org/10.3389/fonc.2020.00669

Ejemplares similares